Literature DB >> 1646780

Potentiation of murine cytomegalovirus pneumonitis by antibiotics in clinical use.

S D Olver1, P Price, K T Karthigasu.   

Abstract

Nineteen antibiotics were screened for their effects on the proliferation of murine spleen cells in vitro. Ketoconazole suppressed lymphoproliferation at clinically-attainable concentrations, whilst tetracycline, cephalothin, rifampicin and ciprofloxacin were also inhibitory at relatively low concentrations. These antibiotics were selected for further study. High concentrations of cephalothin inhibited macrophage uptake of colloidal gold, while spleen cells from mice treated with ketoconazole responded poorly to mitogenic stimulation in vitro. Humoral responses to ovalbumin, polyvinylpyrrolidone and murine cytomegalovirus (MCMV) were not suppressed by oral administration of ketoconazole, tetracycline, cephalothin, rifampicin or ciprofloxacin to mice. However, MCMV-infected mice receiving these antibiotics had increased virus loads and a greater persistence of virus and interstitial pneumonitis in their lungs. This was observed with clinically-attainable serum concentrations of cephalothin, tetracycline and ciprofloxacin. The findings warrant further investigation as the antibiotics are used to control secondary infections in immunosuppressed patients, many of whom experience cytomegalovirus disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646780     DOI: 10.1093/jac/27.1.81

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

Review 1.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

2.  Dendritic cell expression of the signaling molecule TRAF6 is required for immune tolerance in the lung.

Authors:  Daehee Han; Matthew C Walsh; Kwang Soon Kim; Sung-Wook Hong; Junyoung Lee; Jaeu Yi; Gloriany Rivas; Yongwon Choi; Charles D Surh
Journal:  Int Immunol       Date:  2017-02-01       Impact factor: 4.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.